Preference for genetic testing among patients offered participation in the Additional KIF6 Risk Offers Better Adherence to Statins (AKROBATS) trial.S.L. Charland, B.C. Agatep, V. Herrera, E.J. Stanek Multiple factors, including age, therapy prescribed, logistical considerations, and health beliefs, may influence the decision to decline or accept genetic testing under trial conditions. Lack of interest, lack of perceived or potential benefit, and time concerns were primary reasons for study participation/KIF6 test declination. In contrast, belief in personal value/utility, altruism, and general interest appeared to drive study participation/KIF6 test acceptance. Asgenetic testing advances, information such as this is key to fully understanding patients’ attitudes towards acceptance and reservations about genetic testing, and may serve as a basis to develop effective patient communication and education strategies to support individualized decision making. Presented: American Society for Human Genetics, Montreal, Canada Link: http://www.ichg2011.org/pdf/ICHG%20Poster%20Abstracts.pdf |